Status:
RECRUITING
Mass Vaccine and Drug Administration, Bangladesh
Lead Sponsor:
University of Oxford
Conditions:
Plasmodium Falciparum Malaria
Eligibility:
All Genders
6+ years
Phase:
PHASE4
Brief Summary
This is an open i.e. not blinded, cluster-randomised, controlled intervention study. The study will use a factorial design to estimate the protective effectiveness of mass drug administrations, mass v...
Detailed Description
Trial Activities: The investigators are most interested in the combined effect of mass administration of vaccines and drugs on malaria transmission. Can Mass Vaccine and Drug Administrations (MVDA) re...
Eligibility Criteria
Inclusion
- Current residence in a study village irrespective of permanence
- Age 6 months and above (no upper age limit)
- Written informed consent provided by participants (or a parent/guardian in case the participant is under 18 years old)
Exclusion
- Pregnancy, plan to get pregnant, or breastfeeding.
- Acute illness requiring intervention
- A history of an adverse reaction to study drugs/vaccine and prior receipt of any other malaria vaccine or enrolment in another intervention trial.
Key Trial Info
Start Date :
February 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2028
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06068530
Start Date
February 15 2025
End Date
February 1 2028
Last Update
December 18 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Alikadam Upazila Health Complex
Bāndarban, Bangladesh, 4650
2
Lama Upazila Health Complex
Lāma, Bangladesh, 4641